Tarsia Giandomenico, De Michele Mario, Polosa Domenico, Biondi-Zoccai Giuseppe, Costantino Fabio, Del Prete Giuseppe, Osanna Rocco Aldo, Innelli Pasquale, Sisto Francesco, Sheiban Imad, Lisanti Pasquale
Heart Department, San Carlo Hospital, Potenza, Italy.
Heart Vessels. 2010 Jul;25(4):275-81. doi: 10.1007/s00380-009-1198-2. Epub 2010 Jul 31.
Although many thrombectomy devices have been tested in ST-segment elevation acute myocardial infarction (STEMI), there are no comparative data on safety or effectiveness in thrombectomy or ST-segment resolution. This study compares manual versus nonmanual thrombectomy devices in patients undergoing primary or rescue percutaneous coronary intervention in a tertiary care center. We identified 232 consecutive patients with STEMI and time from symptom onset to emergency room contact of < or = 12 h undergoing percutaneous coronary intervention with coronary thrombectomy devices. Primary end point was ST-segment resolution of > or = 70%. Several angiographic, procedural and clinical secondary end points were also evaluated. The manual thrombectomy group included 110 patients and the nonmanual group 122 patients. Both groups were similar in their clinical characteristics. The primary end point occurred with similar frequency in patients treated with manual versus nonmanual thrombectomy (67.9% vs 60.0%, P = 0.216). No significant differences were found in the two groups with regard to procedural complications, angiographic reperfusion parameters, in-hospital major adverse cardiac events, or infarct size, whereas manual thrombectomy was associated with a better left ventricle ejection fraction at discharge. Furthermore, treatment with a manual thrombectomy device was associated with significantly shorter procedural times (69 min vs 95 min, P < 0.001) and lower procedural costs (2981 euros vs 7505 euros, P < 0.001). The use of manual thrombus-aspiration catheters appeared equivalent to nonmanual thrombectomy devices in the setting of primary or rescue percutaneous intervention in terms of clinical efficacy, and led to shorter procedures and cost savings.
尽管许多血栓切除术装置已在ST段抬高型急性心肌梗死(STEMI)中进行了测试,但在血栓切除术或ST段恢复方面,尚无关于安全性或有效性的比较数据。本研究在一家三级医疗中心对接受初次或补救性经皮冠状动脉介入治疗的患者中,比较了手动与非手动血栓切除术装置。我们确定了232例连续的STEMI患者,其症状发作至急诊室就诊时间≤12小时,接受了冠状动脉血栓切除术装置的经皮冠状动脉介入治疗。主要终点是ST段恢复≥70%。还评估了几个血管造影、手术和临床次要终点。手动血栓切除术组包括110例患者,非手动组包括122例患者。两组的临床特征相似。手动与非手动血栓切除术治疗的患者中,主要终点出现的频率相似(67.9%对60.0%,P = 0.216)。两组在手术并发症、血管造影再灌注参数、院内主要不良心脏事件或梗死面积方面未发现显著差异,而手动血栓切除术与出院时更好的左心室射血分数相关。此外,使用手动血栓切除术装置与显著更短的手术时间(69分钟对95分钟,P < 0.001)和更低的手术成本(2981欧元对7505欧元,P < 0.001)相关。在初次或补救性经皮介入治疗中,就临床疗效而言手动血栓抽吸导管的使用似乎等同于非手动血栓切除术装置,并导致手术时间缩短和成本节约。